User profiles for Caius G. Radu
Caius G. RaduProfessor of Pharmacology, University of California Los Angeles Verified email at mednet.ucla.edu Cited by 10595 |
[HTML][HTML] Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications
SS Yaghoubi, DO Campbell, CG Radu, J Czernin - Theranostics, 2012 - ncbi.nlm.nih.gov
Positron emission tomography (PET) imaging reporter genes (IRGs) and PET reporter
probes (PRPs) are amongst the most valuable tools for gene and cell therapy. PET IRGs/PRPs …
probes (PRPs) are amongst the most valuable tools for gene and cell therapy. PET IRGs/PRPs …
Differences in promiscuity for antibody–FcRn interactions across species: implications for therapeutic antibodies
Preclinical tests of therapeutic antibodies are frequently carried out in mice to evaluate
pharmacokinetics and efficacy. However, the observation that mouse IgG are cleared rapidly from …
pharmacokinetics and efficacy. However, the observation that mouse IgG are cleared rapidly from …
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
Pharmacologic inhibition of KRAS G12D in pancreatic cancer models with an intact immune
system stimulates specific, potent, and durable tumor regressions. In the absence of overt …
system stimulates specific, potent, and durable tumor regressions. In the absence of overt …
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells
Cellular immunity has an inherent high level of functional heterogeneity. Capturing the full
spectrum of these functions requires analysis of large numbers of effector molecules from …
spectrum of these functions requires analysis of large numbers of effector molecules from …
DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins
Whether for pathological examination or for fundamental biology studies, different classes of
biomaterials and biomolecules are each measured from a different region of a typically …
biomaterials and biomolecules are each measured from a different region of a typically …
Mapping the site on human IgG for binding of the MHC class I‐related receptor, FcRn
JK Kim, M Firan, CG Radu, CH Kim… - European journal of …, 1999 - Wiley Online Library
The analysis of the pharmacokinetics of wild‐type and mutated Fc fragments derived from
human IgG1 indicates that Ile253, His310 and His435 play a central role in regulating serum …
human IgG1 indicates that Ile253, His310 and His435 play a central role in regulating serum …
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma
…, TA McCannel, A Ishiyama, J Czernin, CG Radu… - Clinical Cancer …, 2014 - AACR
Purpose: It has been demonstrated that large numbers of tumor-specific T cells for adoptive
cell transfer (ACT) can be manufactured by retroviral genetic engineering of autologous …
cell transfer (ACT) can be manufactured by retroviral genetic engineering of autologous …
[HTML][HTML] Migration to apoptotic “find-me” signals is mediated via the phagocyte receptor G2A
Phagocytosis of apoptotic cells is fundamentally important throughout life, because non-cleared
cells become secondarily necrotic and release intracellular contents, thus instigating …
cells become secondarily necrotic and release intracellular contents, thus instigating …
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
The EGFR/PI3K/Akt/mTOR signaling pathway is activated in many cancers including
glioblastoma, yet mTOR inhibitors have largely failed to show efficacy in the clinic. Rapamycin …
glioblastoma, yet mTOR inhibitors have largely failed to show efficacy in the clinic. Rapamycin …
Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog
Monitoring immune function with molecular imaging could have a considerable impact on
the diagnosis and treatment evaluation of immunological disorders and therapeutic immune …
the diagnosis and treatment evaluation of immunological disorders and therapeutic immune …